登士柏西诺德股价波动，机构关注业绩修复前景

Core Viewpoint - The stock price of Dentsply Sirona (NASDAQ: XRAY) has experienced significant fluctuations over the past week, reflecting market sentiment regarding the recovery expectations in the dental industry [1] Group 1: Stock Performance - On February 12, the stock price fell by 6.78% to close at $12.78, with a trading range of 7.15% [1] - The stock had previously increased by 1.68% to $13.93 on February 10, but then decreased by 1.58% to $13.71 on February 11 [1] - Overall, the stock has seen a cumulative decline of 7.12% with a total volatility of 10.25%, reaching a low of $12.77 [1] Group 2: Institutional Perspectives - Institutional interest in Dentsply is high, but recent ratings are cautious, with only 11% of 18 institutions recommending buy or hold, while 83% suggest holding and 6% recommend selling [2] - The target price range is between $11.00 and $16.00, with an average target price of $12.75, which is close to the current stock price [2] - Earnings forecasts indicate a projected year-over-year decline of 32.79% in earnings per share for Q4 2025, with a slight revenue increase of 0.73% year-over-year [2] Group 3: Recent Events - There have been no major company announcements recently, but the market is focused on the prospects for performance recovery [3] - Dentsply is expected to release its full-year financial report for 2025 in Q1 2026, where management may update details on the "return to growth" strategy [3] - The dental industry's digitalization trend and aging population are expected to provide long-term support, although compliance with global medical device regulations (such as EU MDR) should be monitored [3]